- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01268696
Genetic Assessment of the Patients With Metabolic Syndrome (GENMetS)
Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population
Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:
weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.
Study Overview
Status
Conditions
Detailed Description
Eligibility criteria to the study:
- patients with metabolic syndrome
- with written consent
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Lodz, Poland
- Department of medical biotechnology Medical University of Lodz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with metabolic syndrome according to IDF,AHA and NHLBI 2009
Exclusion Criteria:
- diabetes type 1
- cancer
- not consent
- steroid therapy
- alcohol or drug abuse
- chronic inflammatory disease
- pregnancy or lactation
- severe hypothyroidism
- immunosuppressive treatment
- operation or severe injury during the last month
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
control group
healthy volunteers
|
Metabolic group
Patients with metabolic syndrome
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Tadeusz Pietrucha, prof., Department of medical biotechnology
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RNN/202/10/KE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Mayo ClinicCompleted
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
-
Andalas UniversityHasanuddin University; Universitas Sumatera UtaraCompletedMetabolic Syndrome, Protection AgainstIndonesia